Olanzapine (APO-Olanzapine ODT)
What to know about Olanzapine — also sold as APO-Olanzapine ODT, Olanzapine Sandoz ODT 5, PRYZEX ODT, Zypine ODT, OLANZAPINE ODT-WGR and 15 more: uses, side effects, interactions, and safety considerations for people taking it or caring for someone who is.
Olanzapine (brand names: APO-Olanzapine ODT, Olanzapine Sandoz ODT 5, PRYZEX ODT, Zypine ODT, OLANZAPINE ODT-WGR and 15 more) is classified as Moderate risk (4 risk points) by AllMeds. It is a S4 medication under the TGA in Australia. Atypical antipsychotic with significant sedation, metabolic effects, and QTc prolongation risk.
Key Takeaways
- TGA Schedule: S4 in Australia
- Risk level: Moderate (4 points)
- CNS depressant: May cause sedation, impair driving, and affect work capacity
- PBS listed: Subsidised under the Australian Pharmaceutical Benefits Scheme
Scheduling and Classification
| Jurisdiction | Classification | Status |
|---|---|---|
| Australia (TGA) | S4 | PBS listed |
Risk Profile
Atypical antipsychotic with significant sedation, metabolic effects, and QTc prolongation risk.
How Olanzapine is regulated
Olanzapine is overseen by medicines regulators in each country. The rules below explain how it's scheduled, what oversight applies, and what to discuss with your doctor or pharmacist before starting, changing, or stopping this medication.
Work capacity impact: As a CNS depressant, Olanzapine may impair driving, operating machinery, and cognitive function. Work capacity certificates should reflect any medication-related restrictions.
Australia TGA / PBS / State Schemes
Classified as S4 under the Therapeutic Goods Administration (TGA).
Listed on the Pharmaceutical Benefits Scheme (PBS) for subsidised prescribing.
Check this medication against your full medication list
Run a full risk assessment including Olanzapine interactions and compliance checks.
Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.
Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.